A phase 2 trial of the GSK-3 inhibitor tideglusib in progressive supranuclear palsy

Author:

Tolosa Eduardo1,Litvan Irene2,Höglinger Günter U.34,Burn David5,Lees Andrew6,Andrés María V.7,Gómez-Carrillo Belén7,León Teresa8,del Ser Teodoro9,

Affiliation:

1. Neurology Service, Hospital Clinic de Barcelona; Universidad de Barcelona; Institut d'Investigacions Biomédiques August Pi i Sunyer (IDIBAPS), Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED) Barcelona Spain

2. Movement Disorders Program; University of California San Diego; San Diego California USA

3. Department of Neurology; Philipps Universitat; Marburg Germany

4. Department of Neurology; Technische Universität, München, German Center for Neurodegenerative Diseases (DZNE); München Germany

5. Institute for Ageing and Health; Newcastle University; Newcastle Upon Tyne United Kingdom

6. Reta Lila Weston Institute; London United Kingdom

7. Clinical Department; Noscira SA; Madrid Spain

8. Clinical Operations and Medical Affairs Department; Noscira SA; Madrid Spain

9. Medical Department; Noscira SA; Madrid Spain

Publisher

Wiley

Subject

Neurology (clinical),Neurology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3